Search Results - "Fiere, D"

Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus by Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., Fiere, D., Lortholary, O., Maertens, J., Meis, J. F., Patterson, T. F., Ritter, J., Selleslag, D., Shah, P. M., Stevens, D. A., Walsh, T. J.

“…During the past several decades, there has been a steady increase in the frequency of opportunistic invasive fungal infections (IFIs) in immunocompromised…”
Get full text

Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors by OOSTERVELD, M, MUUS, P, WILLEMZE, R, GRATWOHL, A, FERRANT, A, MANDELLI, F, CORTES, J, DE WITTE, T, ESTEY, E, SUCIU, S, KOLLER, C, VERHOEF, G, LABAR, B, WIJERNIANS, P, AUL, C, FIERE, D, SELLESLAG, D

“…Comparisons of the effectiveness of chemotherapy and transplantation in AML in first complete remission (CR) have focused almost exclusively on patients with…”
Get full text

Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia by THOMAS, X, LE, Q. H, FIERE, D

“…We describe three cases of acute promyelocytic leukemia (APL) with long-term disease-free survival who developed congestive heart failure (CHF) requiring…”
Get full text

Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience by PICARD, C, HAYETTE, S, VAERMAN, J. L, DAVI, F, DASTUGUE, N, RAYNAUD, S, LAFAGE, M, DESCHASEAUX, F, FEST, T, GAUB, M. P, LHERITIER, V, THOMAS, X, BILHOU-NABERA, C, CHARRIN, C, BOUCHEIX, C, DOMBRET, H, MACINTYRE, E, FIERE, D, GABERT, J, CAYUELA, J. M, DELABESSE, E, FRENOY, N, PREUDHOMME, C, DUPONT, M, BASTARD, C, BORIES, D

Get full text

Adult T‐biphenotypic acute leukaemia: clinical and biological features and outcome by Rubio, M. T., Dhedin, N., Boucheix, C., Bourhis, J. H., Reman, O., Boiron, J. M., Gallo, J. H., Lhéritier, V., Thomas, X., Fière, D., Vernant, J. P.

“…Biphenotypic acute leukaemia with T‐lymphoid and myeloid markers is rare and poorly documented. In the Leucemie Aigue Lymphoblastique de l'Adulte (LALA)…”
Get full text

Clinical Significance of Multidrug Resistance P-Glycoprotein Expression on Acute Nonlymphoblastic Leukemia Cells at Diagnosis by Campos, Lydia, Guyotat, Denis, Archimbaud, Eric, Calmard-OrioL, Pascale, Tsuruo, Takashi, Troncy, Jacques, Treille, Danielle, Fiere, Denis

“…To evaluate the clinical value of the expression of multidrug resistance P-glycoprotein (P-170) on the surface of acute nonlymphoblastic leukemia (ANLL) cells,…”
Get full text

Influence of cigarette smoking on the presentation and course of acute myeloid leukemia by Chelghoum, Y., Danaïla, C., Belhabri, A., Charrin, C., Le, Q.-H., Michallet, M., Fiere, D., Thomas, X.

“…Background: It is known that cigarette smoking is associated with an ∼50% increase in leukemia risk. In order to detect a possible influence of cigarette…”
Get full text

Transplantation with selected autologous peripheral blood CD34 +Thy1 + hematopoietic stem cells (HSCs) in multiple myeloma : Impact of HSC dose on engraftment, safety, and immune reconstitution by Michallet, Mauricette, Philip, Thierry, Philip, Irène, Godinot, Hubert, Sebban, Catherine, Salles, Gilles, Thiebaut, Anne, Biron, Pierre, Lopez, Francis, Mazars, Philippe, Roubi, Nora, Leemhuis, Tom, Hanania, Elie, Reading, Christopher, Fine, Gilbert, Atkinson, Kerry, Juttner, Chris, Coiffier, Bertrand, Fière, Denis, Archimbaud, Eric

“…The aims of our study performed in myeloma were to evaluate the performance and the safety of Systemix's high-speed clinical cell sorter, to assess the safety…”
Get full text

Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period by THOMAS, X, DANAÏLA, C, LE, Q-H, SEBBAN, C, TRONCY, J, CHARRIN, C, LHERITIER, V, MICHALLET, M, MAGAUD, J-P, FIERE, D

“…Although the prospect of long-term leukemia-free survival (LFS) after treatment for adult acute lymphoblastic leukemia (ALL) is widely accepted, few studies…”
Get full text

TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia by Raynaud, S, Mauvieux, L, Cayuela, J M, Bastard, C, Bilhou-Nabera, C, Debuire, B, Bories, D, Boucheix, C, Charrin, C, Fière, D, Gabert, J

Get more information

Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: A retrospective study of 54 cases by Colita, A., Belhabri, A., Chelghoum, Y., Charrin, C., Fiere, D., Thomas, X.

“…Background Since 1976, erythroleukemia has been included within the FAB classification system of acute myeloid leukemia (AML) which designates it as M6 AML…”
Get full text

Fusarium infections in immunocompromised patients : case reports and literature review by RABODONIRINA, M, PIENS, M. A, MONIER, M. F, GUEHO, E, FIERE, D, MOJON, M

“…Five cases are reported of Fusarium infection in patients with aplasia following chemotherapy of leukemia. The clinical signs, diagnosis and course of the…”
Get full text

Treatment of Acute Lymphoblastic Leukemia in the Elderly: An Evaluation of Interferon Alpha Given as a Single Agent After Complete Remission by Delannoy, A., Cazin, B., Thomas, X., Bouabdallah, R., Boiron, J.M., Huguet, F., Straetmans, N., Zérazhi, H., Vernant, J.P., Dombret, H., Bilhou-Nabera, C., Charrin, C., Boucheix, C., Sebban, C., Lhéritier, V., Fière, D.

“…Although interferon (IFN) has been used in elderly patients with acute lymphoblastic leukemia (ALL), the benefits from IFN therapy have not been properly…”
Get full text

Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cells by Gorin, N. C., Labopin, M., Pichard, P., Sierra, J., Fiere, D., Rio, B., Meloni, G., Sanz, M. A., Iriondo, A., Fouillard, L., Frassoni, F.

“…A total of 193 patients with acute myelocytic leukaemia (AML) [147 in first complete remission (CR1)], ranging from 60 years to 75 years of age (median 63…”
Get full text

Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients by DELANNOY, A, SEBBAN, C, GAY, C, BROUSTET, A, MICHAUX, J. L, FIERE, D, CONY-MAKHOUL, P, CAZIN, B, CORDONNIER, C, BOUABDALLAH, R, CAHN, J. Y, DREYFUS, F, SADOUN, A, VERNANT, J. P

“…Acute lymphoblastic leukemia (ALL) in the elderly is characterized by its poor prognosis. Forty patients with ALL, aged 55 years or older, and with good…”
Get full text

Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation by MICHALLET, M, PERSAT, F, KRANZHÖFER, N, LEVRON, J.-C, PRAT, C, BELHABRI, A, CHWETZOFF, E, LE MOING, J.-P, FIERE, D, PIENS, M.-A

“…A prospective study of the pharmacokinetics of itraconazole solution was performed in 11 patients who underwent allogeneic BMT (day of BMT = day 0) after a…”
Get full text

Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma by Moreau, P, Fiere, D, Bezwoda, W R, Facon, T, Attal, M, Laporte, J P, Colombat, P, Haak, H L, Monconduit, M, Lockhorst, H, Girault, D, Harousseau, J L

“…To evaluate the impact of granulocyte-macrophage colony-stimulating factor (GM-CSF) or placebo on the durations of intravenous (IV) antibiotic use,…”
Get more information

Design and validation of a bedside decision instrument to elicit a patient's preference concerning allogenic bone marrow transplantation in chronic myeloid leukemia by Sebban, C, Browman, G, Gafni, A, Norman, G, Levine, M, Assouline, D, Fiere, D

“…The objective of this study was to design and validate a bedside decision instrument to be used by patients with chronic myeloid leukemia and their physicians…”
Get more information

Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-α by MICHALLET, M, THIEBAUT, A, SALLES, B, DUMONTET, C, PEAUD, P. Y, VILQUE, J. P, DEVIDAS, A, FIBRE, D, PHILIP, I, CHARRIN, C, VIGOUROUX, C, THOMAS, X, BILGER, K, BELHABRI, A, GUYOTAT, D, CORRONT, B

“…In chronic myelogenous leukemia (CML), autologous stem cell transplantation could be a promising new approach for patients with no cytogenetic response after…”
Get full text

Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation by MICHALLET, M, PERRIN, M.-C, BELHABRI, A, MOLINA, L, NICOLINI, F, TIGAUD, J. D, SOTTO, J.-J, GUYOTAT, D, FIERE, D, ARCHIMBAUD, E

“…In order to determine whether doses of cyclosporine and methylprednisolone used for prophylaxis and therapy of acute graft-versus-host disease (GVHD) have any…”
Get full text